Velocity’s Hallandale Beach Site Earns Merck’s Significant Contribution to Clinical Trials Award

Merck recently presented Velocity’s Hallandale Beach site with the Significant Contribution to Clinical Trials Award, specifically for being the top enroller of diverse participants in cardiovascular clinical trials in 2023.

We’re grateful for the contributions of our Hallandale Beach site toward improving diversity in clinical trials, both in the workforce and in our participants. We’re also proud to partner with Merck to innovate new and better ways to make clinical trials more accessible for all.

Posted in

Quality. Continuity. Velocity.